Drug details

Baraclude (entecavir)

type of Hepatitis B Hepatitis C Agents

Baraclude (entecavir) is an antiviral nucleoside drug indicated for the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. Baraclude is available in generic form.

This drug may have the following side effects:

• nausea,
• headache,
• vomiting,
• dizziness, or
• diarrhea,
• skin rash,
• upset stomach,
• fatigue,
• temporary hair loss,
• sleep problems (insomnia).

The following drugs are related to Baraclude, either as a replacement or used together:

• Recombinate (antihemophilic factor (recombinant))
• Engerix-B (hepatitis b vaccine recombinant)
• Epivir (lamivudine)
• Epivir-HBV (lamivudine tablets and oral solution)
• Mavyret (glecaprevir and pibrentasvir)
• Havrix (hepatitis a vaccine, inactivated)
• Twinrix (hepatitis a inactivated & hepatitis b (recombinant) vaccine)
• Vaqta (hepatitis a vaccine, inactivated)
• Viread (tenofovir disoproxil fumarate)